Elizaveta Mitkina Tabaksblat

Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms

Hans‐Christian Pommergaard, Kirstine Nielsen, Halfdan Sørbye et al. · Journal of Neuroendocrinology · 2021 · 42 citations · Full text

Medicine, Oncology, Surgery +17

LBA45 Randomized open label phase III study comparing the efficacy and safety of everolimus followed by chemotherapy (CT) with streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs: The SEQTOR study (GETNE 1206)

Ramón Salazar, S. Tafuto, Merete Krogh et al. · Annals of Oncology · 2022 · 30 citations · Full text

Medicine, Oncology, Pharmacology +11

Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

Halfdan Sørbye, Geir Olav Hjortland, Lene Weber Vestermark et al. · British Journal of Cancer · 2025 · 26 citations · Full text

Medicine, Oncology, Pathology +15

Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms

Siren Morken, Seppo W. Langer, Anna Sundlöv et al. · British Journal of Cancer · 2023 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring

Yoo Young Lee, Doan Trang Nguyen, T. B. Moodie et al. · BMC Cancer · 2021 · 13 citations · Full text

Medicine, Oncology, Radiation Oncology +17